Free Trial

Iterum Therapeutics (ITRM) News Today

Iterum Therapeutics logo
$1.18 -0.05 (-3.66%)
As of 02:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Iterum Therapeutics plc stock logo
Short Interest in Iterum Therapeutics plc (NASDAQ:ITRM) Declines By 14.6%
Iterum Therapeutics plc (NASDAQ:ITRM - Get Free Report) saw a large decline in short interest in February. As of February 28th, there was short interest totalling 1,580,000 shares, a decline of 14.6% from the February 13th total of 1,850,000 shares. Based on an average daily trading volume, of 783,000 shares, the days-to-cover ratio is currently 2.0 days. Currently, 4.7% of the shares of the stock are sold short.
Iterum Therapeutics Appoints New Board Members
Iterum Therapeutics files $150M mixed securities shelf
Iterum Therapeutics Regains Full Nasdaq Compliance
Iterum Therapeutics’ Strategic Advances with ORLYNVAH Approval
Iterum Therapeutics sees cash runway into 2025
Iterum Therapeutics PLC trading resumes
Iterum Therapeutics announces FDA approval of Orlynvah
Iterum Therapeutics to Present Data at IDWeek 2024
Iterum secures patents for antibiotic combinations
Iterum Therapeutics Commences Rights Offering
Q1 2024 Iterum Therapeutics PLC Earnings Call
Remove Ads
Get Iterum Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter.

ITRM Media Mentions By Week

ITRM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ITRM
News Sentiment

1.87

0.78

Average
Medical
News Sentiment

ITRM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ITRM Articles
This Week

1

1

ITRM Articles
Average Week

Remove Ads
Get Iterum Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ITRM) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners